Benzoyl ATP is an antagonist of rat and human P2Y1 receptors and of platelet aggregation

Biochemical and Biophysical Research Communications

Volumn 256, Issue 1, 1999, Pages 94-97

  Vigne, Paul ^a   Hechler, Béatrice ^b   Gachet, Christian ^b   Breittmayer, Jean Philippe ^c   Frelin, Christian ^a  

^a INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b INSERM   (France)

^c CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE DERIVATIVE; ADENYLATE CYCLASE; CALCIUM; CYCLIC AMP; PURINE P2 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT;

ANIMAL CELL; ARTICLE; BRAIN CAPILLARY; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; COMPETITIVE INHIBITION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME INHIBITION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; THROMBOCYTE; THROMBOCYTE AGGREGATION;

ANIMALIA;

EID: 0033525551     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1999.9558     Document Type: Article

References (31)

1. Harden T. K., Boyer J. L., Nicholas R. A. Annu. Rev. Pharmacol. Toxicol. 35:1995;541-579.
2. North R. A., Barnard E. A. Curr. Opin. Neurobiol. 7:1997;346-357.
3. Webb T. E., Simon J., Krishek B. J., Bateson A. N., Smart T. G., King B. F., Burnstock G., Barnard E. A. FEBS Lett. 324:1993;219-225.
4. Filtz T. M., Li Q., Boyer J. L., Nicholas R. A., Harden T. K. Mol. Pharmacol. 46:1994;8-14.
5. Henderson D. J., Elliot D. G., Smith G. M., Webb T. E., Dainty I. A. Biochem. Biophys. Res. Commun. 212:1995;648-656.
6. Tokuyama Y., Hara M., Jones E. M. C., Fan Z., Bell G. I. Biochem. Biophys. Res. Commun. 211:1995;211-218.
7. Léon C., Vial C., Cazenave J. P., Gachet C. Gene. 171:1996;295-297.
8. Brown C., Tanna B., Boarder M. R. Br. J. Pharmacol. 116:1995;2413-2416.
9. Schachter J. B., Harden T. K. Br. J. Pharmacol. 121:1997;338-344.
10. Boyer J. L., Romero-Avila T., Schachter J. B., Harden T. K. Mol. Pharmacol. 50:1996;1323-1329.
11. Hechler B., Léon C., Vial C., Vigne P., Frelin C., Cazenave J. P., Gachet C. Blood. 92:1998;152-159.
12. Léon C., Hechler B., Vial C., Leray C., Cazenave J. P., Gachet C. FEBS Lett. 403:1997;26-30.
13. Hechler B., Vigne P., Léon C., Breittmayer J. P., Gachet C., Frelin C. Mol. Pharmacol. 53:1998;727-733.
14. Boyer J. L., Mohanram A., Camaioni E., Jacobson K. A., Harden T. K. Br. J. Pharmacol. 124:1998;1-3.
15. Jin J., Daniel J. L., Kunapuli S. P. J. Biol. Chem. 273:1998;2030-2034.
16. Fagura M. S., Dainty I. A., McKay G. D., Kirk I. P., Humphries R. G., Robertson M. J., Dougall I. G., Leff P. Br. J. Pharmacol. 124:1998;157-164.
17. Savi P., Beauverger P., Labouret C., Delfaud M., Salel V., Kaghad M., Herbert J. M. FEBS Lett. 422:1998;291-295.
18. Surprenant A., Rassendren F., Kawashima E., North R. A., Buell G. Science. 272:1996;735-738.
19. Boyer J. L., Harden T. K. Mol. Pharmacol. 39:1989;831-835.
20. Frelin C., Breittmayer J. P., Vigne P. J. Biol. Chem. 268:1993;8787-8792.
21. Feolde E., Vigne P., Breittmayer J. P., Frelin C. Br. J. Pharmacol. 115:1995;1199-1203.
22. Vigne P., Feolde E., Breittmayer J. P., Frelin C. Br. J. Pharmacol. 112:1994;775-780.
23. Bradford M. M. Anal. Biochem. 72:1976;248-254.
24. Webb T. E., Feolde E., Vigne P., Neary J. T., Runberg A., Frelin C., Barnard E. Br. J. Pharmacol. 119:1996;1385-1392.
25. Nicholas R. A., Watt W., Lazarowski E. R., Li Q., Harden T. K. Mol. Pharmacol. 50:1996;224-229.
26. Hourani S. M. O., Hall D. A. P2 Purinoceptors: Localization, Function and Transduction Mechanisms. 1996;Ciba Foundation Symposia. p. 53-70.
27. Mills D.C. Thromb. Haemost. 76:1996;835-856.
28. Kenakin T. Pharmacol. Rev. 48:1996;413-463.
29. MacKenzie A. B., Mahaut-Smith M. P., Sage S. O. J. Biol. Chem. 271:1996;2879-2881.
30. Vial C., Hechler B., Léon C., Cazenave J. P., Gachet C. Thromb. Haemost. 78:1997;1500-1504.
31. Gachet C., Hechler B., Léon C., Vial C., Leray C., Ohlmann P., Cazenave J. P. Thromb. Haemost. 78:1997;271-275.